ImageneBio Inc

Share · US45175G2075 · IMA (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

19.12.2025 20:59

Current Prices from ImageneBio Inc

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	IMA	USD	19.12.2025 20:59	6,17 USD	-0,02 USD -0,32 %

Share Float & Liquidity

Free Float 69,61 %

Shares Float 7,78 M

Shares Outstanding 11,18 M

Company Profile for ImageneBio Inc Share

Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis

AI Analysis of ImageneBio Inc

Click any analysis below to get instant AI insights from finAgent

Company Data

Name ImageneBio Inc

Company ImageneBio Inc

Symbol IMA

Website https://www.inmagenebio.com

Primary Exchange

NASDAQ

ISIN US45175G2075

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Kristin Yarema

Market Capitalization 69 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 12526 High Bluff Drive, Suite 345, San Diego, CA 92130, 92130 San Diego

IPO Date 1998-02-27

ID Changes

Date	From	To
28.07.2025	IKNA	IMA

Ticker Symbols

Name	Symbol
NASDAQ	IMA

More Shares

Investors who hold ImageneBio Inc also have the following shares in their portfolio:

FIRSTGROUP PLC 5.250% BDS 29/11/22 (BR) GBP Bond

Public Storage Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog